ABX-1431

ABX-1431 · Abide Therapeutics

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ABX-1431, covering 2017-11-06 to 2020-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder [Phase 2]